香港股市 已收市

CORT Nov 2024 25.000 put

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
2.60000.0000 (0.00%)
市場開市。 截至 09:30AM EDT。
全螢幕
前收市價2.6000
開市2.6000
買盤1.1500
賣出價3.6000
拍板25.00
到期日2024-11-15
今日波幅2.6000 - 2.6000
合同範圍
成交量1
未平倉合約1
  • Zacks

    Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Reuters

    Teva sues Corcept over mifepristone 'monopoly' for rare disorder

    Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a rare hormonal disorder called Cushing's syndrome. The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated “a multifaceted scheme to prolong Corcept’s monopoly by stifling competition from Teva at every turn.” Teva accused Corcept of "paying bribes and kickbacks" to physicians to keep them prescribing brand Korlym.

  • Zacks

    Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?

    Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.